<?xml version='1.0' encoding='utf-8'?>
<document id="23475665"><sentence text="High-throughput mass spectrometric cytochrome P450 inhibition screening." /><sentence text="We describe here a high-throughput assay to support rapid evaluation of drug discovery compounds for possible drug-drug interaction (DDI)" /><sentence text=" Each compound is evaluated for its DDI potential by incubating over a range of eight concentrations and against a panel of six cytochrome P450 (CYP) enzymes: 1A2, 2C8, 2C9, 2C19, 2D6, and 3A4" /><sentence text=" The method utilizes automated liquid handling for sample preparation, and online solid-phase extraction/tandem mass spectrometry (SPE/MS/MS) for sample analyses" /><sentence text=" The system is capable of generating two 96-well assay plates in 30 min, and completes the data acquisition and analysis of both plates in about 30 min" /><sentence text=" Many laboratories that perform the CYP inhibition screening automate only part of the processes leaving a throughput bottleneck within the workflow" /><sentence text=" The protocols described in this chapter are aimed to streamline the entire process from assay to data acquisition and processing by incorporating automation and utilizing high-precision instrument to maximize throughput and minimize bottleneck" /><sentence text="" /></document>